Prizes & Recognitions
Our Journey of Success and Recognition
Women TechEU Award Winner – Fanny Giannou
Fanny Giannou was recognized as a Women TechEU Award winner for pioneering innovation in female-led deep tech startups across Europe. She received €75,000 in funding, 6 months of mentorship, and specialized courses to scale her venture.
Discover More
Alithea Bio – CyberChampion 2024
Alithea Bio won the prestigious CyberChampion 2024 award, receiving €10,000 and 6 months of communication mentoring from Nacona Academy. Their innovative solution, aiming to transform cancer immunotherapies, impressed the jury and celebrated the startup’s impact in the tech community.
Alithea Bio – de:hub AI Award 2025 Finalist
Alithea Bio was selected as one of four finalists for the German-wide de:hub AI Award 2025 by BMWK, recognized for its innovative end-to-end cancer immunotherapy platform, HLA-Compass. The nomination highlights the startup’s leadership in AI-driven healthcare solutions.
Discover More
Fanny Giannou – European Prize for Women Innovators 2025 Semi-Finalist
Fanny Giannou was selected as a semi-finalist for the 2025 European Prize for Women Innovators, recognized for her pioneering work in precision immunotherapy and AI-driven cancer drug development. This honor celebrates her impact as a leading female innovator shaping the future of healthcare.
Discover More
Alithea Bio – KI Champions Baden-Württemberg 2025
Alithea Bio was honored as a KI Champion 2025, recognized for its innovation and leadership in AI-driven healthcare solutions. The award highlights the startup’s excellence among 56 applicants in Baden-Württemberg’s prestigious AI competition.
Discover More
Alithea Bio – Innovationspreis Freiburg 2025
Alithea Bio won the Freiburger Innovationspreis 2025 for its HLA‑Compass platform, a SaaS solution using AI and ultra-sensitive mass spectrometry to identify critical HLA peptides. The platform accelerates and refines personalized immunotherapy, advancing cancer research and digital twin applications.
Discover More
Alithea Bio – R&D Seal (FuE-Siegel) Recipient
Alithea Bio has been awarded the German R&D Seal (FuE-Siegel) for excellence in research and development, recognizing scientific novelty, technical complexity, and structured project planning. This milestone affirms the company’s leadership in precision immunotherapy and innovation in biotech.
Discover More
Leading the Future of Precision Immunotherapy
Alithea Bio: Pioneering HLA peptide Characterization with Innovative Immunopeptidomics, highly sensitive Mass Spectrometry and applied AI
